UnitedHealth Group Incorporated (NYSE:UNH) shares traded lower over the last trading session, losing -0.96% on 12/18/20. The shares fell to a low of $334.00 before closing at $338.38. Intraday shares traded counted 8.72 million, which was -181.16% lower than its 30-day average trading volume of 3.10M. UNH’s previous close was $341.67 while the outstanding shares total 950.00M. The firm has a beta of 0.74, a 12-month trailing P/E ratio of 19.44, and a growth ratio of 1.58. The stock’s Relative Strength Index (RSI) is 48.14, with weekly volatility at 1.95% and ATR at 7.36. The UNH stock’s 52-week price range has touched low of $187.72 and a $367.95 high.
Investors have identified the Healthcare Plans company UnitedHealth Group Incorporated as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $324.18 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
UnitedHealth Group Incorporated (UNH) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 54.82 billion total, with 66.6 billion as their total liabilities.
UNH were able to record 14.6 billion as free cash flow during the Q3 2020 quarter of the year, this saw their quarterly net cash flow reduce by 6.57 billion. In cash movements, the company had a total of 16.07 billion as operating cash flow.
Potential earnings growth for UnitedHealth Group Incorporated (UNH)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the Q3 2020 quarter of the year, UnitedHealth Group Incorporated recorded a total of 65.11 billion in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with 7.32% coming in sequential stages and their sales for the Q3 2020 quarter increasing by 4.57%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 49.57 billion trying to sell their products during the last quarter, with the result yielding a gross income of 15.54 billion. This allows shareholders to hold on to 950.00M with the recently reported earning now reading 3.43 cents per share. This is a figure that compared to analyst’s prediction for their Q3 2020 (3.51 cents a share).
Having a look at the company’s valuation, the company is expected to record 18.13 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on UNH sounds very interesting.
Is the stock of UNH attractive?
In related news, Director, BURKE RICHARD T sold 2,500 shares of the company’s stock in a transaction that recorded on Dec 15. The sale was performed at an average price of 340.00, for a total value of 850,000. As the sale deal closes, the Director, BURKE RICHARD T now sold 3,000 shares of the company’s stock, valued at 1,009,500. Also, Director, BURKE RICHARD T sold 2,500 shares of the company’s stock in a deal that was recorded on Dec 10. The shares were price at an average price of 342.00 per share, with a total market value of 855,000. Following this completion of acquisition, the Director, BURKE RICHARD T now holds 7,000 shares of the company’s stock, valued at 2,448,444. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.30%.
20 out of 28 analysts covering the stock have rated it a Buy, while 7 have maintained a Hold recommendation on UnitedHealth Group Incorporated. 0 analysts has assigned a Sell rating on the UNH stock. The 12-month mean consensus price target for the company’s shares has been set at $385.31.